Skip to content

Clinical trials

Burkitt Lymphoma trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Not applicable Country / region: United States Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20022
20036
20045
20053
20063
20072
20082
20092
20104
20112
20142
20151
20162
20191
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated14
Recruiting4
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center8
City of Hope Medical Center4
Masonic Cancer Center, University of Minnesota4
Roswell Park Cancer Institute4
Wake Forest University Health Sciences3
Barbara Ann Karmanos Cancer Institute2
Case Comprehensive Cancer Center2
National Cancer Institute (NCI)2
OHSU Knight Cancer Institute2
University of California, San Francisco2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma52
Precursor Cell Lymphoblastic Leukemia-Lymphoma47
Leukemia, Lymphocytic, Chronic, B-Cell41
Lymphoma, Follicular41
Lymphoma, Large B-Cell, Diffuse41
Lymphoma, Mantle-Cell41
Lymphoma, B-Cell, Marginal Zone40
Lymphoma, Non-Hodgkin39
Lymphoma, Large-Cell, Immunoblastic38
Hodgkin Disease33

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.